How Pregnancy Could Delay Multiple Sclerosis Onset
Pregnancy could delay the onset of multiple sclerosis (MS) by more than 3 years, according to a comprehensive international study led by Monash University researchers, published in JAMA Neurology.
Category: Multiple Sclerosis
Multiple Sclerosis
Popular
Multiple Sclerosis
Latest
Shepherd Center, BurnAlong Partner to Provide Neuro-Based Online Content
BurnAlong, a health and wellness and social motivation platform, and Shepherd Center are collaborating to create and distribute specialty content for people with multiple sclerosis and other neuromuscular diseases worldwide via the BurnAlong online platform.
Multiple Sclerosis
Latest
Gait-Improvement Device for MS Patients Gets FDA OK
The U.S. Food and Drug Administration has authorized the marketing of the Portable Neuromodulation Stimulator (PoNS), a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS).
Expanded Disability Status Scale Identifies Disability in Patients With and Without MS
The Expanded Disability Status Scale (EDSS), which assesses the progression of multiple sclerosis (MS), found both older individuals with and without MS to have significant disability, according to a recent study, per Neurology Advisor.
Read More
Childhood Trauma Has This Effect on Multiple Sclerosis
Childhood trauma could affect the trajectory of multiple sclerosis development and response to treatment in adulthood, according to University of Illinois Urbana-Champaign researchers, in Nature Communications.
Read More
Stem Cell Transplants May Help Prevent Worsening of MS Disability
Intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment, according to a recent study.
Read More
How This Could Spur Seizures in MS Patients
Researchers at the University of California, Riverside School of Medicine have identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures occur in some multiple sclerosis patients. The study was published in ASN Neuro.
Read More
Phase 2 Study of Stem Cell Therapy for MS Suggests Promising Results
NeuroGenesis and Hadassah Medical Center announce positive results from a placebo-controlled Phase 2 clinical trial assessing the impact of NG-01 autologous proprietary subpopulation of mesenchymal stem cells (MSCs) on patients with progressive multiple sclerosis (MS).
Read More
How Gut Immune Cells Put the Brakes on MS
Gut immune cells travel to the brain during multiple sclerosis (MS) flare-ups in patients. These gut cells seem to be playing a protective role, helping drive MS symptoms back into remission, an international research team led by scientists from University of California – San Francisco (UCSF) suggests.
Read More
Fay Horak Discusses Digital Tools for MS Research in Dec. 1 Webinar
Xtalks hosts the free webinar, Digital Technologies for Assessing Patient Functioning in Multiple Sclerosis Clinical Trials, Tuesday, December 1, at 11 am EST.
Read More
Anti-Inflammatory Delivered Intranasally Shows Promise in Slowing MS Progression
Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to researchers from University of Alberta, published in Glia.
Read More
MS Innovation Challenge Aims to Address Unmet Needs
Lyfebulb and Bristol Myers Squibb are now accepting applications for the $25,000 Innovation Challenge award, a partnership initiative that aims to raise awareness about multiple sclerosis (MS) and address unmet needs in its management.
Read More
New Population of Immune Cells Could Drive MS Autoimmunity
Researchers from Thomas Jefferson University have uncovered defining features of a subset of T-cells that may drive autoimmunity in MS, and could prove to be a new target for therapy, they report, in Science Immunology.
Read More
Study Adds to Understanding of MS Progression
Recovery from MS-like symptoms in mice depends on the ability of the CNS’s own immune cells — microglia — to break down the remains of damaged cells, such as myelin, Karolinska Institutet researchers suggest, in Science Immunology.
Read More
Multiple Sclerosis Therapy Possible in Breast Milk
N-acetylglucosamine, a simple sugar found in human breast milk and sold as an over-the-counter dietary supplement in the United States, promotes myelin repair in mouse models and correlates with myelination levels in multiple sclerosis patients, according to a new study led by researchers from University of California, Irvine.
Read More
Watch for These Risk Factors for Unemployment Among Working People with Multiple Sclerosis
A prospective study of employment in multiple sclerosis identifies factors and behaviors that may be targets for interventions to maintain employment. Conducted by Lauren Strober, PhD, from Kessler Foundation, the study is published in Multiple Sclerosis and Related Disorders.
Read More
Most Multiple Sclerosis Patients Face Financial Toxicity, Study Suggests
More than 75% of multiple sclerosis (MS) patients face financial toxicity (hardship) that often results in non-adherence to follow up care, researchers from Harvey L. Neiman Health Policy Institute suggest, in the Multiple Sclerosis Journal.
Read More
How Myelin Sheaths Are Restored After MS or Injury
A research team led by neurobiologist Professor Claire Jacob has identified an important mechanism that can be used to control the restoration of myelin sheaths following traumatic injury and in degenerative diseases, such as multiple sclerosis. Their study is published in Nature Communications.
Read More